RET and thyroid cancer: Based on the MTS data, the IC50 of datelliptium in the Nthy-ori-3-1 cell line was estimated to be 10 μg/mL, four-fold higher than that for TT cells, suggesting that this compound is selectively toxic against mutant RET-driven thyroid cancer.